LeMaitre Vascular, Inc.LMATNASDAQ
Loading
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q4 2025 | 18.96% |
| Q3 2025 | -16.13% |
| Q2 2025 | -13.53% |
| Q1 2025 | 13.18% |
| Q4 2024 | -1.04% |
| Q3 2024 | -14.66% |
| Q2 2024 | 4.69% |
| Q1 2024 | -5.95% |
| Q4 2023 | 3.01% |
| Q3 2023 | -6.47% |
| Q2 2023 | 16.54% |
| Q1 2023 | 9.03% |
| Q4 2022 | 2.66% |
| Q3 2022 | 3.47% |
| Q2 2022 | 14.12% |
| Q1 2022 | -15.19% |
| Q4 2021 | 21.38% |
| Q3 2021 | 7.39% |
| Q2 2021 | -6.75% |
| Q1 2021 | -0.87% |
| Q4 2020 | 36.75% |
| Q3 2020 | -1.92% |
| Q2 2020 | -28.56% |
| Q1 2020 | 19.81% |
| Q4 2019 | 9.56% |
| Q3 2019 | 1.11% |
| Q2 2019 | 0.71% |
| Q1 2019 | -4.56% |
| Q4 2018 | 15.22% |
| Q3 2018 | 2.46% |
| Q2 2018 | 8.93% |
| Q1 2018 | 15.29% |
| Q4 2017 | -10.11% |
| Q3 2017 | 7.77% |
| Q2 2017 | -1.45% |
| Q1 2017 | 9.01% |
| Q4 2016 | -1.17% |
| Q3 2016 | -5.81% |
| Q2 2016 | 13.00% |
| Q1 2016 | -8.19% |